ATR-258 / Atrogi  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ATR-258 / Atrogi
NCT05409924: First-in-human Single and Multiple Dose Trial of ATR-258

Completed
1
71
Europe
ATR-258, Placebo
Atrogi AB, Key2Compliance, CRS Clinical Research Services
Type 2 Diabetes Mellitus
10/23
10/23
Attractive 2, NCT06432673: The Trial - Pharmacokinetics of ATR-258 Oral Capsule vs. Oral Solution Formulations in Healthy Volunteers

Completed
1
21
Europe
ATR-258 Oral solution, ATR-258 Oral capsule
Atrogi AB
Type2diabetes
05/24
05/24

Download Options